Home » Topics » BioWorld

BioWorld
RSS

IMMUNOMEDICS SEEKS EUROPEAN APPROVAL

Nov. 12, 1991

CENTOCOR LOSES $34.9 MILLION IN QUARTER

Nov. 11, 1991

APPOINTMENTS AND ADVANCEMENTS

Nov. 11, 1991

DRUG APPROVAL OVERHAUL PLANS

Nov. 11, 1991

FDA APPROVES NICODERM PATCH

Nov. 11, 1991

CAMBRIDGE NEURO RAISES $18.4 MILLION

Nov. 11, 1991

RATIONAL DESIGN FOR HYPERTENSION DRUG

Nov. 11, 1991

GREENWICH RAISES $15M IN PRIVATE PLACEMENT

Nov. 8, 1991

ATHENA INCREASES SHARES IN OFFERING

Nov. 8, 1991

BTGC FINDS UNIQUE HIV TARGET

Nov. 8, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...